Divi's Laboratories Ltd - Company Profile
Powered by
All the data and insights you need on Divi's Laboratories Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Divi's Laboratories Ltd Strategy Report
- Understand Divi's Laboratories Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Divi's Laboratories Ltd patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
EP3812371B1 | Grant | VERFAHREN ZUR HERSTELLUNG VON BRIVARACETAM | C07B2200/07; C07C239/06; C07D207/12; C07D207/27 | August 31, 2022 |
US11407779B1 | Grant | Process for the preparation of molnupiravir | C07H1/00; C07H19/067 | August 09, 2022 |
US20220241242A1 | Application | ENZYMATIC PROCESS FOR THE PREPARATION OF (2S)-2-[(4R)-2-OXO-4-PROPYL-PYRROLIDIN-1-YL]BUTYRIC ACID AND ITS CONVERSION INTO BRIVARACETAM | A61K31/4015 | August 04, 2022 |
EP4036244A1 | Application | ENZYMATISCHES VERFAHREN ZUR HERSTELLUNG VON (2S)-2-[(4R)-2-OXO-4-PROPYL-PYRROLIDIN-1-YL]BUTTERSÄURE UND DEREN UMWANDLUNG IN BRIVARACETAM | A61K31/4015; C12P17/10; C12Y304/21062 | August 03, 2022 |
US11400074B1 | Grant | Enzymatic process for the preparation of (2S)-2-[(4R)-2-oxo-4-propyl-pyrrolidin-1-yl]butyric acid and its conversion into brivaracetam | A61K31/4015 | August 02, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer